BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16112533)

  • 1. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
    Stewart KM; Cole D
    J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N; Tramonti G; Corti A; Chieli E
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
    J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity.
    Betancor-Fernández A; Pérez-Gálvez A; Sies H; Stahl W
    J Pharm Pharmacol; 2003 Jul; 55(7):981-6. PubMed ID: 12906755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Devil's claw (Harpagophytum procumbens). Also known as 'grapple plant' or 'wood spider'.
    Barnes J
    J Prim Health Care; 2009 Sep; 1(3):238-9. PubMed ID: 20690389
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of degenerative diseases of the musculoskeletal system with South African devil's claw (Harpagophytum procumbens DC)].
    Wegener T
    Wien Med Wochenschr; 1999; 149(8-10):254-7. PubMed ID: 10483693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.).
    Wegener T; Lüpke NP
    Phytother Res; 2003 Dec; 17(10):1165-72. PubMed ID: 14669250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
    Joubert E; Manley M; Gray BR; Schulz H
    J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety.
    Brien S; Lewith GT; McGregor G
    J Altern Complement Med; 2006 Dec; 12(10):981-93. PubMed ID: 17212570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease.
    Whitehouse LW; Znamirowska M; Paul CJ
    Can Med Assoc J; 1983 Aug; 129(3):249-51. PubMed ID: 6407745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of major and minor constituents of Harpagophytum procumbens (Devil's claw) using HPLC-SPE-NMR and HPLC-ESIMS/APCIMS.
    Clarkson C; Staerk D; Hansen SH; Smith PJ; Jaroszewski JW
    J Nat Prod; 2006 Sep; 69(9):1280-8. PubMed ID: 16989520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fight against Infection and Pain: Devil's Claw (
    Gxaba N; Manganyi MC
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems.
    Georgiev MI; Alipieva K; Orhan IE
    Phytother Res; 2012 Feb; 26(2):313-6. PubMed ID: 21721061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations.
    Modarai M; Suter A; Kortenkamp A; Heinrich M
    J Pharm Pharmacol; 2011 Mar; 63(3):429-38. PubMed ID: 21749392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.
    Menghini L; Recinella L; Leone S; Chiavaroli A; Cicala C; Brunetti L; Vladimir-Knežević S; Orlando G; Ferrante C
    Phytother Res; 2019 Sep; 33(9):2152-2162. PubMed ID: 31273865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Devil's claw root: ulcers and gastrointestinal bleeding?
    Prescrire Int; 2013 Dec; 22(144):296. PubMed ID: 24600731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
    Inaba K; Murata K; Naruto S; Matsuda H
    J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of Neutrophil Reactive Oxygen Species Production by Extracts of Devil's Claw (Harpagophytum).
    Muzila M; Rumpunen K; Wright H; Roberts H; Grant M; Nybom H; Sehic J; Ekholm A; Widén C
    Oxid Med Cell Longev; 2016; 2016():3841803. PubMed ID: 27429708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
    Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
    Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.